Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Century Therapeutics Inc is a biotechnology company harnessing the power of allogeneic pluripotent stem cell therapies to develop potentially curative cell therapy products for autoimmune diseases, including type 1 diabetes, or T1D, and cancer. Its...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Century Therapeutics (NASDAQ:IPSC) through any online brokerage.
Other companies in Century Therapeutics’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
Century Therapeutics has a consensus price target of $7.29.
The stock price for Century Therapeutics (NASDAQ: IPSC) is $1.53 last updated October 2, 2026 at 4:01 PM EDT.
There are no upcoming dividends for Century Therapeutics.
Century Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for Century Therapeutics.
Century Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.